SHJBF (Shanghai Junshi Biosciences Co) Beneish M-Score: -2.44 (As of Jun. 24, 2026)


SHJBF Shanghai Junshi Biosciences Co Ltd SHJBF
66 GF Score
Price $3.35
GF Value $6.14
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Shanghai Junshi Biosciences Co Beneish M-Score?

Shanghai Junshi Biosciences Co SHJBF +11.67% 66 Beneish M-Score is -2.44 as of Jun. 24, 2026. GuruFocus rates SHJBF with a GF Score™ of 66/100 and a GF Value™ of $6.14 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 831 Biotechnology companies, Shanghai Junshi Biosciences Co ranks better than 52.23% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.44 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Shanghai Junshi Biosciences Co's Beneish M-Score or its related term are showing as below:

SHJBF' s Beneish M-Score Range Over the Past 10 Years
Min: -5.41   Med: -2.11   Max: 722.05
Current: -2.44

During the past 10 years, the highest Beneish M-Score of Shanghai Junshi Biosciences Co was 722.05. The lowest was -5.41. And the median was -2.11.


Shanghai Junshi Biosciences Co Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Shanghai Junshi Biosciences Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Junshi Biosciences Co Beneish M-Score Chart

Shanghai Junshi Biosciences Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.73 -3.97 -1.81 -2.41 -2.44

Shanghai Junshi Biosciences Co Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -2.73 -2.41 -3.24 -2.44

SHJBF vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, Shanghai Junshi Biosciences Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Junshi Biosciences Co Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Junshi Biosciences Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Shanghai Junshi Biosciences Co's Beneish M-Score falls into.


SHJBF
66GF Score
Shanghai Junshi Biosciences Co Ltd SHJBF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Junshi Biosciences Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Shanghai Junshi Biosciences Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7751+0.528 * 0.9408+0.404 * 1.219+0.892 * 1.3256+0.115 * 1.1491
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.8004+4.679 * -0.026324-0.327 * 1.0863
=-2.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was $71.9 Mil.
Revenue was $354.7 Mil.
Gross Profit was $280.5 Mil.
Total Current Assets was $632.9 Mil.
Total Assets was $1,760.4 Mil.
Property, Plant and Equipment(Net PPE) was $750.8 Mil.
Depreciation, Depletion and Amortization(DDA) was $39.8 Mil.
Selling, General, & Admin. Expense(SGA) was $223.3 Mil.
Total Current Liabilities was $399.2 Mil.
Long-Term Debt & Capital Lease Obligation was $404.7 Mil.
Net Income was $-119.4 Mil.
Gross Profit was $0.0 Mil.
Cash Flow from Operations was $-73.1 Mil.
Total Receivables was $70.0 Mil.
Revenue was $267.6 Mil.
Gross Profit was $199.1 Mil.
Total Current Assets was $588.4 Mil.
Total Assets was $1,483.4 Mil.
Property, Plant and Equipment(Net PPE) was $634.6 Mil.
Depreciation, Depletion and Amortization(DDA) was $39.0 Mil.
Selling, General, & Admin. Expense(SGA) was $210.5 Mil.
Total Current Liabilities was $348.1 Mil.
Long-Term Debt & Capital Lease Obligation was $275.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(71.948 / 354.728) / (70.023 / 267.6)
=0.202826 / 0.26167
=0.7751

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(199.082 / 267.6) / (280.507 / 354.728)
=0.743954 / 0.790766
=0.9408

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (632.909 + 750.804) / 1760.419) / (1 - (588.38 + 634.605) / 1483.386)
=0.213987 / 0.175545
=1.219

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=354.728 / 267.6
=1.3256

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(38.99 / (38.99 + 634.605)) / (39.826 / (39.826 + 750.804))
=0.057883 / 0.050372
=1.1491

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(223.298 / 354.728) / (210.456 / 267.6)
=0.629491 / 0.786457
=0.8004

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((404.677 + 399.247) / 1760.419) / ((275.522 + 348.061) / 1483.386)
=0.456666 / 0.420378
=1.0863

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-119.393 - 0 - -73.051) / 1760.419
=-0.026324

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Shanghai Junshi Biosciences Co has a M-score of -2.44 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.44 mean?
Shanghai Junshi Biosciences Co (SHJBF) has a Beneish M-Score of -2.44 as of Jun. 24, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanghai Junshi Biosciences Co and its competitors. According to the industry distribution chart, Shanghai Junshi Biosciences Co ranks #397 out of 831 companies in the Biotechnology industry, placing it in the top 47.8%.
Is Shanghai Junshi Biosciences Co's Beneish M-Score too high?
Shanghai Junshi Biosciences Co's current Beneish M-Score is -2.44. Based on the distribution chart, Shanghai Junshi Biosciences Co ranks #397 out of 831 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Shanghai Junshi Biosciences Co has a GF Score™ of 66/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Shanghai Junshi Biosciences Co's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Junshi Biosciences Co ranks #397 out of 831 companies for Beneish M-Score. This puts Shanghai Junshi Biosciences Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Shanghai Junshi Biosciences Co and its competitors. Shanghai Junshi Biosciences Co's current Beneish M-Score is -2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Junshi Biosciences Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co (SHJBF) is currently considered Possible Value Trap. The stock's GF Value™ is $6.14, compared to a current price of $3.35 — trading 45.4% below its estimated fair value. The current Beneish M-Score is -2.44. Shanghai Junshi Biosciences Co's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Shanghai Junshi Biosciences Co (SHJBF), the current Beneish M-Score is -2.44 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai Junshi Biosciences Co (SHJBF) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai Junshi Biosciences Co stock appears to be undervalued. The current stock price of $3.35 is trading 45.4% below its estimated GF Value™ of $6.14. GuruFocus considers Shanghai Junshi Biosciences Co to be Possible Value Trap.

Key valuation signals for SHJBF:

  • Beneish M-Score: -2.44
  • GF Value™: $6.14 vs. price of $3.35 (45.4% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the SHJBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai Junshi Biosciences Co Business Description

Other Exchanges 01877:Hong Kong688180:China
Address No. 987 Cai Lun Road, Level 4, China (Shanghai) Pilot Free Trade Zone, Shanghai, CHN
Shanghai Junshi Biosciences Co Ltd is mainly involved in the discovery, development, and commercialisation of therapeutic drugs. It focuses on the development and commercialization of several kinds of drugs, ranging from monoclonal antibodies to various drug modalities, including small molecules, ADCs, bi-specific or multi-specific antibodies, fusion proteins, nucleic acid drugs, and vaccines, as well as the exploration of next-generation therapies, including those for cancer and autoimmune diseases. The Group's portfolio includes commercialized drugs such as Tuoyi, Junmaikang, Mindewei, and Junshida, as well as products in clinical studies or in the marketing application stage. Geographically, it derives maximum revenue from Mainland China, and the rest from USA, India, and other markets.
66GF Score

Get the complete analysis for SHJBF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.35
Price
$6.14
GF Value